StockData
MDNYSEServices-HospitalsFiscal year ends December 31

Pediatrix Medical Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$27.30−0.08 (-0.29%)

Close on Oct 19, 2026

Market cap
$2.22B
P/E (TTM)
13.1
Dividend yield
–

Pediatrix Medical Group, Inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Net patient service revenue [Member]$418.70M$405.35M$421.55M$422.18M$397.41M$389.38M$430.25M$438.68M$432.85M$421.83M$425.48M$437.32M85.8%+5.4%
Hospital contract administrative fees [Member]$68.31M$69.92M$69.99M$67.73M$68.22M$65.18M$71.56M$72.41M$70.91M$71.80M$71.39M$68.71M14.0%+0.1%
Other revenue [Member]$779.00K$924.00K$2.23M$2.97M$3.21M$3.80M$558.00K$70.00K$536.00K$1.47M–$579.00K0.2%-75.7%

By region

From the segment and revenue-disaggregation notes of Pediatrix Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.